Publications by authors named "Mitsuko Mouri"
Article Synopsis
- This study analyzed the cost-effectiveness of using oral S-1 therapy instead of standard intravenous taxane therapy for treating first-line metastatic breast cancer.
- Data from a randomized phase III trial (SELECT BC) was used, revealing that S-1 provided slightly better quality-adjusted life years (QALY) and lower overall costs compared to taxane treatment.
- The findings indicate that S-1 therapy has a high likelihood of being cost-effective, with a 92% chance of being a viable option when considering a specific willingness to pay threshold for additional health benefits.
The frequency of hip fractures associated with aging of the population is declining in many countries. Even in Japan, where this frequency has been increasing continually, a shift to decreasing frequency has been noted in recent reports. The objective of this study was to investigate the effects of this decrease and to estimate the number of hip fracture patients and the resulting reduction in national medical care expenditures.
View Article and Find Full Text PDFObjective: Deep brain stimulation (DBS) is an effective surgical option for treating Parkinson's disease (PD). DBS is invasive, with a high initial cost. In Japan, questions have been raised about its cost-effectiveness and the resulting improvements in outcome.
View Article and Find Full Text PDF